LFG
LXRX icon

Larson Financial Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Larson Financial Group’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$156 Hold
100
– – ﹤0.01% 3480
2025
Q4 		$115 Hold
100
– – ﹤0.01% 3325
2025
Q3 		$135 Hold
100
– – ﹤0.01% 3296
2025
Q2 		$95 Hold
100
– – ﹤0.01% 3169
2025
Q1 		$46 Hold
100
– – ﹤0.01% 2994
2024
Q4 		$74 Hold
100
– – ﹤0.01% 2655
2024
Q3 		$157 Hold
100
– – ﹤0.01% 2439
2024
Q2 		$168 Buy
+100
New +$179 ﹤0.01% 2120

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Larson Financial Group's LXRX Position: Q1 2026 in Review

Larson Financial Group held its Lexicon Pharmaceuticals (LXRX) position steady in Q1 2026 at 100 shares worth $156. The position accounts for ﹤0.01% of the portfolio, ranked #3480.

Larson Financial Group first reported a position in LXRX in Q2 2024 and has held it in 8 quarters since. The position peaked at $168 in Q2 2024. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Larson Financial Group held 100 shares of Lexicon Pharmaceuticals worth $156 as of Q1 2026.
  • Larson Financial Group left its Lexicon Pharmaceuticals share count unchanged in Q1 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #3480 holding.
  • Larson Financial Group first reported a position in Lexicon Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • Larson Financial Group's Lexicon Pharmaceuticals position peaked at $168 in Q2 2024.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.